Cenra Balance Sheet Health
Financial Health criteria checks 6/6
Cenra has a total shareholder equity of NT$7.4B and total debt of NT$2.7B, which brings its debt-to-equity ratio to 36.9%. Its total assets and total liabilities are NT$12.6B and NT$5.1B respectively. Cenra's EBIT is NT$328.8M making its interest coverage ratio 6.2. It has cash and short-term investments of NT$495.5M.
Key information
36.9%
Debt to equity ratio
NT$2.74b
Debt
| Interest coverage ratio | 6.2x |
| Cash | NT$495.52m |
| Equity | NT$7.44b |
| Total liabilities | NT$5.11b |
| Total assets | NT$12.56b |
Recent financial health updates
We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06Recent updates
China Chemical & Pharmaceutical's (TWSE:1701) Dividend Will Be Reduced To NT$0.50
Jul 12Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching
Apr 25We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On
Mar 17China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 24Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?
Jan 27
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On
Dec 16China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 26Financial Position Analysis
Short Term Liabilities: 1701's short term assets (NT$5.5B) exceed its short term liabilities (NT$3.8B).
Long Term Liabilities: 1701's short term assets (NT$5.5B) exceed its long term liabilities (NT$1.4B).
Debt to Equity History and Analysis
Debt Level: 1701's net debt to equity ratio (30.2%) is considered satisfactory.
Reducing Debt: 1701's debt to equity ratio has reduced from 56.8% to 36.9% over the past 5 years.
Debt Coverage: 1701's debt is well covered by operating cash flow (23.2%).
Interest Coverage: 1701's interest payments on its debt are well covered by EBIT (6.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/04 05:46 |
| End of Day Share Price | 2024/09/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cenra Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wei Zheng Kit | Citigroup Inc |
| Ryan Liu | IBTS Investment Consulting Co., Ltd. |
| Regina Lee | Jih Sun Securities Investment Consulting Co., Ltd. |